Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
GHRP-2 structure

GHRP-2

Growth Hormone
Phase 2 Research
55%
Low-Moderate Risk
2/5

Dosing Protocol

Typical Dose 150 mcg
Range 100 - 300 mcg
Maintenance 150 mcg 2-3x daily

Pharmacokinetics

Half-Life 33 min
Onset 5 min
Peak 15 min
Duration 1.5 hrs
Bioavailability 95%
Primary Route Subcutaneous

Administration

Routes Subcutaneous, Intravenous
Injection Sites Abdomen, Thigh, Deltoid
Needle Gauge 29-31G
Syringe Type Insulin
Timing Before Bed, Fasted, Post-Workout

Reconstitution

Diluent Bacteriostatic Water
Volume 2 mL
Concentration 2500 mcg/mL
Stability 21 days refrigerated
Vial Sizes 5 mg

Special Instructions

Less hunger stimulation than GHRP-6. Used clinically in Japan for GH deficiency diagnosis.